Final Salvo? Galvus Infringement Case Simmers In India

 
• By Anju Ghangurde

Natco has sprung a challenge to Novartis’ vildagliptin patent in India, months before its expiry. The Indian firm will hold back further release of its product on the market amid legal action and it remains to be seen if Novartis will pursue damages.

PatentPuzzle
Novartis Seeks To Block Infringement Of Galvus Patent In India • Source: Shutterstock

More from India

More from Focus On Asia